Mini-webinar: Disparities in kidney care and the role of cystatin C

30. Nov 2023 | 4 min read

Mini-webinar: Disparities in kidney care and the role of cystatin C

In the series of mini-webinars on cystatin C and kidney health our Global Product Manager for Cystatin C Mr. Gaute Tangen, focuses on cystatin C eGFR (Estimated Glomerular Filtration Rate) as a potential enhancer of accuracy and reliability of estimating kidney function.

 

Watch webinar:  Disparities in kidney care

In this webinar we will look into the two articles published in The New England Journal of Medicine discussing how the new creatinine- and cystatin C-Based equations to estimate GFR can help overcome challenges related to disparities in kidney diagnostics:

 

 

Watch the webinar on YouTube

 

Previous mini-webinar: Cystatin C, creatinine and eGFR equations

This webinar discuss the origins of disparities in kidney care, starting from the context within the United States connected to the process towards unbiased GFR assessments:

  • Cystatin C for earlier diagnosis of CKD
  • The recommendation to remove the race factor from creatinine equations
  • The ideal combination of creatinine and cystatin C


Watch the webinar on YouTube

 

The background: Disparities in kidney care and cystatin C

A joint taskforce by the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) recommends increased utilisation of cystatin C in combination with creatinine for more unbiased GFR assessments. The European Kidney Function Consortium (EKFC) has followed up on the initiative from the Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi) addressing the race factor in eGFR equations in a recent study with data from over 227 000 patients. Based on the results they have developed a new cystatin C-based eGFR equation that doesn't factor in race or gender, ensuring accurate GFR estimation without compromising precision compared to creatinine equations.

 

The Gentian Cystatin C Immunoassay

Gentian Diagnostics introduced its turbidimetric cystatin C immunoassay in 2006. The the open-channel test shows a well-documented accuracy across various clinical chemistry analysers, offering rapid results in as little as 10 minutes.

  • FDA510(k) cleared and CE-marked
  • IVDR certified
  • Developed and manufactured by Gentian
  • Manufactured according to ISO 13485:2016

 

Interested in cystatin C

Explore cystatin C in clinical settings or in your laboratory - fill out the form or send an email to marketing@gentian.com for more information about the product and prices.

 

 

 

 

You may also read


Discussing cystatin C at ASN Kidney Week 2024

Oct 18, 2024

Discussing cystatin C at ASN Kidney Week 2024

Meet us at Kidney Week at booth #1833 ASN Kidney Week is a great occasion for renal health care providers to..

Retinol-Binding Protein Webinar: The assay and its clinical utility

Oct 17, 2024

Retinol-Binding Protein Webinar: The assay and its clinical utility

Retinol-Binding Protein (RBP) - Protein and nutritional status Retinol-Binding Protein (RBP) is a low..

See you at

Oct 11, 2024

See you at "Lederdagene" - Nordic event

Meet Gentian at "Lederdagene" in Bodø, Norway Gentian Diagnostics look forward to attend NITO Lederdagene..